In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Royal Numico NV

www.numico.com

Latest From Royal Numico NV

People In Brief: Soller consults, Sharaf joins AHPA, Perrigo hires Crabill, Villaraigosa advises Herbalife

Soller leaves UCSF to consult full-time; Aker hires former Clavis Pharma scientists for krill R&D; Perrigo adds nutritional regulatory manager; USP veteran Sharaf joins AHPA; ex-mayor of Los Angeles advises Herbalife; FDA’s Plaisier earns permanent ORA appointment; more People In Brief.

Consumer Leadership

People In Brief: Soller consults, Sharaf joins AHPA, Perrigo hires Crabill, Villaraigosa advises Herbalife

Soller leaves UCSF to consult full-time; Aker hires former Clavis Pharma scientists for krill R&D; Perrigo adds nutritional regulatory manager; USP veteran Sharaf joins AHPA; ex-mayor of Los Angeles advises Herbalife; FDA’s Plaisier earns permanent ORA appointment; more People In Brief.

Consumer Leadership

Deal Statistics Quarterly, Q2 2000

In Vivo introduces a new quarterly feature, a statistical review compiled from our Strategic Transactions database. In this edition, we include financings by type (IPO, private placement etc.); financings by sector (surgical equipment, implantable devices, etc.); alliances by therapeutic category (cardiovascular, orthopedic, etc.); alliances by industry segment (biomaterials, monitoring equipment, etc. ); for three separate industries: medical devices, in vitro diagnostics, and pharmaceuticals/biotechnology.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Numico
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Royal Numico NV
  • Senior Management
  • J.C.T. van der Wielen, Pres. & CEO
  • Contact Info
  • Royal Numico NV
    Phone: (31) 79 353 90 00
    2700 MA Zoetermeer
    P.O. Box 1
    Zoetermeer,
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register